ANDROGEN RECEPTOR MODULATOR AND USES THEREOF

There is described herein a pharmaceutical composition comprising a nonaqueous, lipid-based solution of the compound of Formula (I) in a softgel capsule, wherein the composition comprises the compound of Formula (I), vitamin E d-.alpha.-tocopheryl polyethylene glycol 1000 succinate NF (Vitamin E TPG...

Full description

Saved in:
Bibliographic Details
Main Authors SMITH, NICHOLAS D, HERBERT, MARK R, HAGER, JEFFREY H, MANEVAL, EDNA CHOW, CHEN, ISAN
Format Patent
LanguageEnglish
French
Published 27.06.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:There is described herein a pharmaceutical composition comprising a nonaqueous, lipid-based solution of the compound of Formula (I) in a softgel capsule, wherein the composition comprises the compound of Formula (I), vitamin E d-.alpha.-tocopheryl polyethylene glycol 1000 succinate NF (Vitamin E TPGS), polyethylene glycol 400 NF/EP (PEG 400), glycerol monocaprylocaprate EP and caprylocaproyl macroglycerides EP/NF (see formula I) Il est décrit une composition pharmaceutique dans laquelle une solution à base de lipide non aqueuse du composé de la formule (I) est enveloppée par une capsule molle. La composition en question se compose du composé de la formule (I), de la vitamine E d-a-tocophéryle polyéthylène glycol 1000 succinate NF (vitamine E TPGS), du polyéthylène glycol 400 NF/EP (PEG 400), du glycérol monocaprylocaprate EP et des macoglycérides caprycaproylique EP/NF (voir la formule I).
Bibliography:Application Number: CA20143105552